United States - English - NLM (National Library of Medicine)

lannett company, inc. - verapamil hydrochloride (unii: v3888oey5r) (verapamil - unii:cj0o37ku29) - verapamil hydrochloride 120 mg - verelan (verapamil hcl) is indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including this drug. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program's joint national committee on prevention, detection, evaluation, and treatment of high blood pressure (jnc). numerous antihypertensive drugs, from a variety of pharmacologic classes and with diffe

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - verapamil hydrochloride (unii: v3888oey5r) (verapamil - unii:cj0o37ku29) - verapamil hydrochloride 240 mg - verelan (verapamil hcl) is indicated for the management of essential hypertension. verapamil hcl is contraindicated in: - severe left ventricular dysfunction. (see warnings. ) - hypotension (less than 90 mm hg systolic pressure) or cardiogenic shock. - sick sinus syndrome (except in patients with a functioning artificial ventricular pacemaker). - second - or third-degree av block (except in patients with a functioning artificial ventricular pacemaker). - patients with atrial flutter or atrial fibrillation and an accessory bypass tract (e.g., wolff-parkinson-white, lown-ganong-levine syndromes). (see warnings. ) - patients with known hypersensitivity to verapamil hydrochloride.

United States - English - NLM (National Library of Medicine)

lannett company, inc. - verapamil hydrochloride (unii: v3888oey5r) (verapamil - unii:cj0o37ku29) - verapamil hydrochloride 100 mg - verelan® pm (verapamil hydrochloride extended-release capsules) for oral use is indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including this drug. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program's joint national committee on prevention, detection, evaluation, and treatment of high blood pressure (jnc). numerous antihypertensive drugs,

United States - English - NLM (National Library of Medicine)

bryant ranch prepack - verapamil hydrochloride (unii: v3888oey5r) (verapamil - unii:cj0o37ku29) - verapamil hydrochloride 300 mg

European Union - English - EMA (European Medicines Agency)

novartis europharm ltd - serelaxin - heart failure - other vasodilators used in cardiac diseases - treatment of acute heart failure

Canada - English - Health Canada

recro gainesville llc - verapamil hydrochloride - capsule (sustained-release) - 240mg - verapamil hydrochloride 240mg - miscellaneous calcium-channel blocking agents

Canada - English - Health Canada

recro gainesville llc - verapamil hydrochloride - capsule (sustained-release) - 180mg - verapamil hydrochloride 180mg - miscellaneous calcium-channel blocking agents

Canada - English - Health Canada

recro gainesville llc - verapamil hydrochloride - capsule (sustained-release) - 120mg - verapamil hydrochloride 120mg - miscellaneous calcium-channel blocking agents

Philippines - English - FDA (Food And Drug Administration)

ambica int'l trading corp - alprazolam - tablet - 500mcg

Philippines - English - FDA (Food And Drug Administration)

ambica international corporation; distributor: ambica international corporation - alprazolam - tablet - 250mcg